PET/CT identifies breast cancer tumors not detected by other methods

07/16/2010 | HealthImaging.com

The use of 18F-FDG PET/CT helped pinpoint in 40 out of 89 breast cancer patients tumor deposits that were not detected through other tests, including mammography, CT and ultrasound. "Our findings agree with other studies in promoting regular investigations such as tumor markers and 18F-FDG PET/CT rather than awaiting the developments of physical symptoms as suggested by current guidelines since the timely detection of early recurrence may have a major impact on therapy and survival," the researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health